G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has been challenging.

Treatment seems to have been effective, but it is not clear whether such bespoke therapies can be widely applied.

Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing Crispr therapies.